Article: Clinical Trials in Alzheimer's Disease: A Hurdle in the Path of Remedy.
International journal of Alzheimer's disease
2020 Volume 2020, Page(s) 5380346
Abstract: ... test "disease-modifying drugs," i.e., therapeutic agents that specifically modify pathological features ...
Abstract | Human clinical trials seek to ameliorate the disease states and symptomatic progression of illnesses that, as of yet, are largely untreatable according to clinical standards. Ideally, clinical trials test "disease-modifying drugs," i.e., therapeutic agents that specifically modify pathological features or molecular bases of the disease and would presumably have a large impact on disease progression. In the case of Alzheimer's disease (AD), however, this approach appears to have stalled progress in the successful development of clinically useful therapies. For the last 25 years, clinical trials involving AD have centered on beta-amyloid (A |
---|---|
Language | English |
Publishing date | 2020-04-01 |
Publishing country | United States |
Document type | Journal Article ; Review |
ZDB-ID | 2573333-3 |
ISSN | 2090-0252 ; 2090-8024 |
ISSN (online) | 2090-0252 |
ISSN | 2090-8024 |
DOI | 10.1155/2020/5380346 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.